Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal? @DovePress https://t.co/ag5zhmjqDM
Inhaled Corticosteroids Prescribed for #COPD Patients with Mild or Mode | COPD @DovePress https://t.co/fby2qIJm1v @davdiaper @jalojer @Jesusrgtej @GolpeRafael #EPOC @banavarrete
Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Mode | COPD @DovePress https://t.co/jlVSVknVjw
Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal? https://t.co/pjT20KXkIZ https://t.co/ACRliaFKaZ
Interesting read @murph_ac
New study finds 39% of #COPD patients with mild or moderate airflow limitation prescribed ICS were suitable for withdrawal according to GOLD guidelines. https://t.co/aRNOGImnCX @ljdaines @AHutchinsonHull @stonny999 @stuartberry1 @DarushAttar
[Article Metrics] Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Mode | COPD @DovePress https://t.co/f5jI0aA2TW
RT @DovePress: Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withd…
Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal? https://t.co/r2VEdhUriE